Xiangling Chu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study.
Journal: Signal transduction and targeted therapy
Published: October 11, 2024
PMS2 amplification contributes brain metastasis from lung cancer.
Journal: Biological procedures online
Published: March 01, 2024
A retrospective study of first-line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations.
Journal: Cancer medicine
Published: February 27, 2024
Full spectrum flow cytometry-powered comprehensive analysis of PBMC as biomarkers for immunotherapy in NSCLC with EGFR-TKI resistance.
Journal: Biological procedures online
Published: June 15, 2023
Indoor air pollution: An important risk factor for lung cancer among Asian women without a history of smoking.
Journal: Chinese medical journal pulmonary and critical care medicine
Published: October 30, 2022
Erratum to "Predicting checkpoint inhibitors pneumonitis in non-small cell lung cancer using a dynamic online hypertension nomogram" [Lung Cancer 170 (2022) 74-84].
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 02, 2022
Pulmonary adverse events associated with hypertension in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors.
Journal: Frontiers in pharmacology
Published: May 15, 2022
Predicting checkpoint inhibitors pneumonitis in non-small cell lung cancer using a dynamic online hypertension nomogram.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 12, 2022
Treatment of small cell lung cancer: recent advances.
Journal: Current opinion in oncology
Published: October 26, 2021
Low baseline plasma PCSK9 level is associated with good clinical outcomes of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Journal: Thoracic cancer
Published: October 21, 2021
Last Updated: 09/26/2026